MedTrace Logo

Effect of Inspiratory Muscle Training on Ventilated Patients in an Intensive Care Unit

NCT06611683 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-10-03

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if inspiratory muscle training facilite the liberation of mechanical ventilation. The main questions it aims to answer are:

Does inspiratory muscle training facilitate weaning from mechanical ventilation and enhance muscle strength in critically ill, subacute adult patients?

The main questions it aims to answer are:

Does pulmonary rehabilitation facilitate wwaning form mechanical patients? Does the intervention improve respiratory muscle strength and respiratory patterns?

Participants received:

Inspriatory muscle training twice daily for three consecutive weeks or until the subject no longer required ventilator support.

Conditions

  • Critically Ill, Subacute Adult Patients
  • Mechanically Ventilation

Interventions

PROCEDURE

Inspiratory muscle training

A threshold inspiratory muscule device used a starting resistance set at 30% maximum inspiratory pressure, connecting to subject artificial airway. The subjects were then instructed to perform fast and forceful inspirations against added inspiratory resistance. The inspiratory muscle training was conducted twice daily over five consecutive days, followed by a two-day rest period. This regimen continued for three consecutive weeks or until the subject no longer required ventilator support.

PROCEDURE

Routine care

Subjects received routine care without intervention.

Sponsors & Collaborators

  • Zuoying Armed Forces General Hospital

    collaborator UNKNOWN

  • Kaohsiung Chang Gung Memorial Hospital,Taiwan

    collaborator UNKNOWN

  • Chang Gung University

    lead OTHER

Principal Investigators

  • Shu-Jane Wang, MS · Zuoying Armed Forces General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06611683 on ClinicalTrials.gov